繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Phrebitum调整2026财年收入前景;引入27财年指引

2025-12-09 07:13

  • Backed by strong fiscal 2026 Q3 financial results, Phreesia is narrowing its revenue guidance range for the year.
  • The software-as-a-service and payment platform provider for the healthcare industry now sees FY26 revenues (ending Jan. 31, 2026) of $479M-$481M. Consensus is $485.88M. 
  • Phreesia also released FY27 revenue guidance (year ends Jan. 31, 2027) of $545M-$559M. Consensus is 569.51M.
  • The company added it expects 6.5% of its FY27 revenue to come from its AccessOne acquisition

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。